Kim HJ, et al. - In this prospective, double-blind, single-center, randomized, controlled superiority trial, researchers investigated how the quality of postoperative recovery in patients undergoing robotic gastrectomy was influenced by deep neuromuscular blockade vs moderate neuromuscular blockade. In a 1:1 ratio, they randomized 56 adult patients (aged 19-80 years) scheduled for elective robotic gastrectomy to a moderate neuromuscular blockade group or a deep neuromuscular blockade group. A post-tetanic count of 1-2 or a train-of-four count of 1-2, respectively, was maintained by adjusting the infusion rate for rocuronium in the deep and moderate neuromuscular blockade groups. Findings revealed similar effect on postoperative quality of recovery for deep and moderate neuromuscular blockade. Overall, study results suggested that deep neuromuscular blockade during robotic gastrectomy may be unnecessary, at least in patients with normal body mass index.